Coronavirus-Disrupted Drug Firm's $23M Ch. 11 Sale OK'd
A Delaware bankruptcy judge on Friday signed off on the $23 million sale of diabetes drug technology company Valeritas Holdings Inc., which cited the coronavirus outbreak's impact on its Chinese factories...To view the full article, register now.
Already a subscriber? Click here to view full article